Benedict‐Tilman Berger

1.7k total citations
50 papers, 904 citations indexed

About

Benedict‐Tilman Berger is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Benedict‐Tilman Berger has authored 50 papers receiving a total of 904 indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 13 papers in Oncology and 11 papers in Organic Chemistry. Recurrent topics in Benedict‐Tilman Berger's work include Protein Kinase Regulation and GTPase Signaling (8 papers), Ubiquitin and proteasome pathways (8 papers) and Protein Degradation and Inhibitors (8 papers). Benedict‐Tilman Berger is often cited by papers focused on Protein Kinase Regulation and GTPase Signaling (8 papers), Ubiquitin and proteasome pathways (8 papers) and Protein Degradation and Inhibitors (8 papers). Benedict‐Tilman Berger collaborates with scholars based in Germany, United States and United Kingdom. Benedict‐Tilman Berger's co-authors include Stefan Knapp, Susanne Müller, A. Chaikuad, Matthew B. Robers, Stefan Laufer, Thomas Hanke, James D. Vasta, Lena M. Berger, Martin Schröder and Andreas Krämer and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

Benedict‐Tilman Berger

47 papers receiving 885 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Benedict‐Tilman Berger Germany 19 590 207 197 121 79 50 904
Wang‐Qing Liu France 20 805 1.4× 194 0.9× 283 1.4× 114 0.9× 74 0.9× 54 1.2k
Elena Casale Italy 15 602 1.0× 256 1.2× 253 1.3× 135 1.1× 113 1.4× 28 965
Bainan Wu United States 22 880 1.5× 150 0.7× 244 1.2× 118 1.0× 31 0.4× 28 1.2k
Matthias Rabiller Germany 12 962 1.6× 293 1.4× 449 2.3× 140 1.2× 66 0.8× 13 1.3k
Martin Schröder Germany 21 678 1.1× 142 0.7× 284 1.4× 83 0.7× 72 0.9× 45 1.3k
Arwin Aban United States 9 575 1.0× 211 1.0× 165 0.8× 66 0.5× 36 0.5× 13 748
John M. Hatcher United States 16 574 1.0× 252 1.2× 211 1.1× 68 0.6× 63 0.8× 33 967
Matthäus Getlik Germany 15 964 1.6× 324 1.6× 456 2.3× 148 1.2× 107 1.4× 18 1.3k
Renaud Prudent France 18 687 1.2× 186 0.9× 188 1.0× 91 0.8× 26 0.3× 37 1.1k
Gongqin Sun United States 24 1.1k 1.8× 188 0.9× 273 1.4× 63 0.5× 86 1.1× 77 1.4k

Countries citing papers authored by Benedict‐Tilman Berger

Since Specialization
Citations

This map shows the geographic impact of Benedict‐Tilman Berger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benedict‐Tilman Berger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benedict‐Tilman Berger more than expected).

Fields of papers citing papers by Benedict‐Tilman Berger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benedict‐Tilman Berger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benedict‐Tilman Berger. The network helps show where Benedict‐Tilman Berger may publish in the future.

Co-authorship network of co-authors of Benedict‐Tilman Berger

This figure shows the co-authorship network connecting the top 25 collaborators of Benedict‐Tilman Berger. A scholar is included among the top collaborators of Benedict‐Tilman Berger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benedict‐Tilman Berger. Benedict‐Tilman Berger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schwalm, Martin P., L M Wahl, Andreas Krämer, et al.. (2025). Un-LOK-ing a New Approach for Conformational Selective Targeting of STK10 (LOK). ACS Medicinal Chemistry Letters. 16(11). 2086–2096.
2.
Krämer, Andreas, Tran Do Hoang Nhu, Andreas C. Joerger, et al.. (2024). Back-Pocket Optimization of 2-Aminopyrimidine-Based Macrocycles Leads to Potent EPHA2/GAK Kinase Inhibitors. Journal of Medicinal Chemistry. 67(15). 12534–12552. 8 indexed citations
3.
Pan, Yufeng, Benedict‐Tilman Berger, Michael Förster, et al.. (2024). Probing the Protein Kinases′ Cysteinome by Covalent Fragments. Angewandte Chemie International Edition. 64(8). e202419736–e202419736. 5 indexed citations
4.
Pan, Yufeng, Benedict‐Tilman Berger, Michael Förster, et al.. (2024). Untersuchung der Adressierbarkeit des Cysteinoms der Proteinkinasen durch Kovalente Fragmente. Angewandte Chemie. 137(8). 1 indexed citations
5.
Reinecke, Maria, P. Brear, Larsen Vornholz, et al.. (2023). Chemical proteomics reveals the target landscape of 1,000 kinase inhibitors. Nature Chemical Biology. 20(5). 577–585. 35 indexed citations
6.
7.
Tredup, Claudia, Natalie Schneider, Sonia Youhanna, et al.. (2023). Deep Annotation of Donated Chemical Probes (DCP) in Organotypic Human Liver Cultures and Patient-Derived Organoids from Tumor and Normal Colorectum. ACS Chemical Biology. 18(4). 822–836.
8.
Němec, Václav, Prashant Khirsariya, Pavlína Janovská, et al.. (2023). Discovery of Potent and Exquisitely Selective Inhibitors of Kinase CK1 with Tunable Isoform Selectivity. Angewandte Chemie. 135(11). 1 indexed citations
9.
Schwalm, Martin P., Lena M. Berger, James D. Vasta, et al.. (2022). A Toolbox for the Generation of Chemical Probes for Baculovirus IAP Repeat Containing Proteins. Frontiers in Cell and Developmental Biology. 10. 886537–886537. 10 indexed citations
10.
Mozos, Igor Ruiz de los, Michael Kluge, Benedict‐Tilman Berger, et al.. (2022). CDK11 regulates pre-mRNA splicing by phosphorylation of SF3B1. Nature. 609(7928). 829–834. 43 indexed citations
11.
Berger, Benedict‐Tilman, et al.. (2022). Resistance to kinase inhibition through shortened target engagement. Molecular & Cellular Oncology. 9(1). 2029999–2029999. 3 indexed citations
12.
Lyczek, Agatha, Benedict‐Tilman Berger, Steven K. Albanese, et al.. (2021). Mutation in Abl kinase with altered drug-binding kinetics indicates a novel mechanism of imatinib resistance. Proceedings of the National Academy of Sciences. 118(46). 40 indexed citations
13.
Berger, Benedict‐Tilman, Martin Schröder, Deep Chatterjee, et al.. (2021). Development of a Selective Dual Discoidin Domain Receptor (DDR)/p38 Kinase Chemical Probe. Journal of Medicinal Chemistry. 64(18). 13451–13474. 5 indexed citations
14.
Berger, Benedict‐Tilman, Marta Amaral, Daria B. Kokh, et al.. (2021). Structure-kinetic relationship reveals the mechanism of selectivity of FAK inhibitors over PYK2. Cell chemical biology. 28(5). 686–698.e7. 50 indexed citations
15.
Němec, Václav, Lukáš Maier, Benedict‐Tilman Berger, et al.. (2021). Highly selective inhibitors of protein kinases CLK and HIPK with the furo[3,2-b]pyridine core. European Journal of Medicinal Chemistry. 215. 113299–113299. 18 indexed citations
16.
Robers, Matthew B., Jennifer Wilkinson, James D. Vasta, et al.. (2021). Single tracer-based protocol for broad-spectrum kinase profiling in live cells with NanoBRET. STAR Protocols. 2(4). 100822–100822. 14 indexed citations
17.
Schröder, Martin, Caroline S. Widdowson, A. Chaikuad, et al.. (2020). Selective targeting of the αC and DFG-out pocket in p38 MAPK. European Journal of Medicinal Chemistry. 208. 112721–112721. 20 indexed citations
18.
Krämer, Andreas, et al.. (2020). Optimization of pyrazolo[1,5-a]pyrimidines lead to the identification of a highly selective casein kinase 2 inhibitor. European Journal of Medicinal Chemistry. 208. 112770–112770. 38 indexed citations
19.
Robers, Matthew B., K. Huber, Laura E. Kilpatrick, et al.. (2020). Quantifying Target Occupancy of Small Molecules Within Living Cells. Annual Review of Biochemistry. 89(1). 557–581. 39 indexed citations
20.
Berger, Benedict‐Tilman, Martin Schröder, A. Chaikuad, et al.. (2019). Fast Iterative Synthetic Approach toward Identification of Novel Highly Selective p38 MAP Kinase Inhibitors. Journal of Medicinal Chemistry. 62(23). 10757–10782. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wang‐Qing Liu Breakdown of academic impact, for papers by Elena Casale Breakdown of academic impact, for papers by Bainan Wu Breakdown of academic impact, for papers by Matthias Rabiller Breakdown of academic impact, for papers by Martin Schröder Breakdown of academic impact, for papers by Arwin Aban Breakdown of academic impact, for papers by John M. Hatcher Breakdown of academic impact, for papers by Matthäus Getlik Breakdown of academic impact, for papers by Renaud Prudent Breakdown of academic impact, for papers by Gongqin Sun
Rankless by CCL
2026